AMC Entertainment shares are trading flat Wednesday afternoon as investors await the company's third-quarter earnings report.

Amgen remains a compelling long-term buy, supported by robust R&D investment and a promising drug pipeline for future growth.

AMD shares ($AMD) get a new forecast after 5-star UBS analyst Timothy Arcuri raised its price target to $300 from $265, ...

DraftKings Inc. DKNG is scheduled to report third-quarter 2025 results on Nov. 6, after the closing bell. In the last ...

Discover whether investing in Groww's IPO is wise as India's fintech landscape evolves amid market uncertainties and high ...

Theater company AMC Entertainment (NYSE:AMC) will be announcing earnings results this Wednesday afternoon. Here’s what you ...

Groww is among India's largest stock brokers, holding a 26.3% market share of active NSE clients as of June 2025; Should you ...

If you’re looking to minimize litigation risk, opt-in consent is realistically the only thing that works,” said Elliot Golding, a partner at McDermott Will & Schulte. “But that’s a tough pill for a ...

Jefferies remains bullish on India Inc., flagging ITC, Dabur, Navin Fluorine, NTPC, and Swiggy as top buys with double-digit ...

Get a deeper insight into the potential performance of AMC Entertainment (AMC) for the quarter ended September 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the ...

Check out our earnings calendar for this week, as well as our previews and recaps of the more noteworthy reports.

Early investors in Groww, including Peak XV, Tiger Global and Y Combinator, are set for multi-fold returns as the $7 billion ...